Home › NDC Lookup › RxCUI directory › RxCUI 200251

Potassium phosphate 155 MG / sodium phosphate, dibasic 852 MG / sodium phosphate, monobasi... — RxCUI 200251

RxNorm drug concept · Semantic clinical drug
RxCUI 200251 Semantic clinical drug · SCD ● Current RxNorm concept 3 FDA products 4 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI200251
Official namePotassium phosphate 155 MG / sodium phosphate, dibasic 852 MG / sodium phosphate, monobasic 130 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asK+ phosphate 155 MG / Sodium Phosphate, Dibasic 852 MG / Sodium Phosphate, Monobasic 130 MG Oral Tablet; sodium phosphate, dibasic 852 MG / potassium phosphate, monobasic 155 MG / sodium phosphate, monobasic 130 MG Oral Tablet; Pot phosphate 155 MG / Sodium Phosphate, Dibasic 852 MG / Sodium Phosphate, Monobasic 130 MG Oral Tablet
FDA products mapped3
Package NDCs mapped4
Reported Medicaid activity (SDUD)28,571 prescriptions · 42 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Potassium Phosphates: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Great question. This IV form is used when your phosphate levels are too low to safely wait for a pill to work, or when you're not able to eat or take anything by mouth right now. I...
  • Why am I getting this through an IV instead of just taking a phosphorus pill?
  • It depends on how serious your kidney issues are. If you have severe kidney disease or are on dialysis, this specific product cannot be used — your kidneys would struggle to clear...
  • Is it safe to get this if I have kidney problems?
📖 Read our full Potassium Phosphates guide →

🕸️ Concept Web — How Potassium phosphate 155 MG / sodium phosphate, d... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Potassium phosphate 155 MG / sodium phosphate, dibasic 852 MG / sodium phosphate, monobasic 130 MG Oral Tablet RxCUI 200251

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 4

    The active substance itself — no strength, form, or brand attached yet.

    • Potassium phosphate 34322
    • Sodium phosphate, dibasic 236719
    • Sodium phosphate, monobasic 235496
    • Potassium phosphate / sodium phosphate, dibasic / sodium phosphate, monobasic 1008010
  2. Brand names 2

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • K-Phos Neutral 217852
    • Phospha 250 Neutral 607414
  3. Dose forms 12

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Potassium phosphate / sodium phosphate, dibasic / sodium phosphate, monobasic Oral Tablet 385063
    • Potassium phosphate / sodium phosphate, dibasic / sodium phosphate, monobasic Oral Product 1165145
    • Potassium phosphate / sodium phosphate, dibasic / sodium phosphate, monobasic Pill 1165146
    • Potassium phosphate / sodium phosphate, dibasic / sodium phosphate, monobasic Oral Tablet [K-Phos Neutral] 1251240
    • Potassium phosphate / sodium phosphate, dibasic / sodium phosphate, monobasic Oral Tablet [Phospha 250 Neutral] 656741
    • K-Phos Neutral Oral Product 1167918
    • K-Phos Neutral Pill 1167919
    • Phospha 250 Neutral Oral Product 1180637
    • +4 more in this family
  4. Clinical & branded drugs 7

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 21 of 25 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Potassium phosphate 155 MG SCDC · 330758
  • Sodium phosphate, dibasic 852 MG SCDC · 336200
  • Sodium phosphate, monobasic 130 MG SCDC · 392925
  • Potassium phosphate / sodium phosphate, dibasic / sodium phosphate, monobasic Oral Tablet SCDF · 385063
  • Potassium phosphate / sodium phosphate, dibasic / sodium phosphate, monobasic Oral Product SCDG · 1165145
  • Potassium phosphate / sodium phosphate, dibasic / sodium phosphate, monobasic Pill SCDG · 1165146

Brand-Name Concepts

📦 FDA Products & Package NDCs

3 products · 4 package NDCs
4 package NDCs map to RxCUI 200251 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00486-1125-01 100 TABLET, COATED in 1 BOTTLE (0486-1125-01) K Phos Neutral Beach Products, Inc. 1977-04-11
00486-1125-05 500 TABLET, COATED in 1 BOTTLE (0486-1125-05) K Phos Neutral Beach Products, Inc. 1977-04-11
64980-0104-01 100 TABLET in 1 BOTTLE (64980-104-01) Dibasic Sodium Phosphate, Monobasic Potassium Phosphate and Monobasic Sodium Phosphate Rising Pharma Holdings, Inc. 2012-06-28
64980-0729-01 100 TABLET in 1 BOTTLE (64980-729-01) PHOSPHA 250 NEUTRAL Rising Pharma Holdings, Inc. 2026-03-28
Observed labelers: Beach Products, Inc. (2) · Rising Pharma Holdings, Inc. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.